A year after Shedeur Sanders' stunning fall from first-round hopeful to late-round draft pick, another perplexing passer was ...

Luxturna was the first FDA-approved gene therapy for a disease caused by mutations in a specific gene. It helped establish ...

Researchers at University of Tsukuba have demonstrated that tomato mutants lacking the SlIAA9 gene, an auxin signaling ...

Regeneron reached an agreement with the U.S. government to link current and future drug prices to those in other developed ...

Researchers have used modified CRISPR to silence the extra chromosome 21 in Down syndrome cells, showing promising ...

Henderson, of course, boasted a 75.4 winning percentage (123-40) during his seven-year tenure as Moore’s varsity coach. He ...

Seeking to make a statement on drug accessibility, the biotech giant will offer its 'groundbreaking' Otarmeni therapy at no ...

More than two in five U.S. adults have prediabetes, a condition marked by higher-than-normal blood sugar levels that often ...

The skin over a fresh wound might not look like much. In some animals, though, that thin covering becomes command central for ...

Three scientists have won the 2026 Breakthrough Prize for developing Luxturna — the world's first FDA-approved gene therapy ...

Not intended for UK Media Ametefgene parvec (AB-1005) manufactured at Viralgen commercial manufacturing facility with next-generation process to deliver high-purity product with greater efficiency ...